Viewing Study NCT00786643



Ignite Creation Date: 2024-05-05 @ 8:02 PM
Last Modification Date: 2024-10-26 @ 9:57 AM
Study NCT ID: NCT00786643
Status: COMPLETED
Last Update Posted: 2012-03-01
First Post: 2008-11-03

Brief Title: Study of Gamma Interfereon in Metastatic Colorectal Carcinoma
Sponsor: Accelerated Community Oncology Research Network
Organization: Accelerated Community Oncology Research Network

Study Overview

Official Title: Phase II Study of Gamma Interferon IFN-γ Added to Bolus Infusional 5-Fluorouracil 5-FU and Leucovorin LV - Bevacizumab BV in Metastatic Colorectal Carcinoma
Status: COMPLETED
Status Verified Date: 2012-02
Last Known Status: None
Delayed Posting: No
If Stopped, Why?: Not Stopped
Has Expanded Access: False
If Expanded Access, NCT#: N/A
Has Expanded Access, NCT# Status: N/A
Acronym: GFL
Brief Summary: The purpose of this study is to evalute the response and toxicity of metastatic colorectal cancer patients to the regimen of gamma interferon added to bolus and infusional 5-fluorouracil and leucovorin GFL with or without bevacizumab
Detailed Description: None

Study Oversight

Has Oversight DMC: None
Is a FDA Regulated Drug?: None
Is a FDA Regulated Device?: None
Is an Unapproved Device?: None
Is a PPSD?: None
Is a US Export?: None
Is an FDA AA801 Violation?: None